PARACETAMOL & CODEINE is a brand name for Acetaminophen (also known as Paracetamol). The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: This medicine is indicated in patients older than 12 years of age. For the short term treatment of acute moderate pain which is not considered to be relieved by other analgesics (e.g. paracetamol, ibuprofen or aspirin) alone, such as: headache, migraine, period pain, dental pain, neuralgia, rheumatic and muscular pain…
Verbatim from this product's MHRA label. Tap a section to expand.
For oral administration Adults One to two capsules, if necessary, three or four times daily at intervals of not less than four hours, up to maximum of eight capsules in 24 hours. Children aged 16 to 18 years One or two capsules every 6 hours when necessary up to a maximum of eight capsules in 24 hours.
Children aged 12 to 15 years One capsule every 6 hours when necessary up to a maximum of four capsules in 24 hours. 4). Elderly In the elderly, the rate and extent of paracetamol absorption is normal, but plasma half-life is longer, and paracetamol clearance is lower than in young adults.
Elderly patients may require a reduced dose or frequency of dosing. Treatment goals and discontinuation Before initiating treatment with Paracetamol & Codeine Capsules, treatment duration and treatment goals, should be agreed together with the patient, in accordance with pain management guidelines.
Duration of treatment Do not take for more than 3 days continuously without medical review. The duration of treatment should be as short as possible, and if no effective pain relief is achieved the patients/carers should be advised to seek the views of a healthcare professional.
Codeine The most common side effects are nausea, vomiting, constipation, dry mouth, sweating, skin rashes and other allergic reactions. Dizziness, drowsiness and pruritus may occur with frequency not known. Regular prolonged use of codeine is known to lead to addiction and symptoms of restlessness and irritability may result when treatment is then stopped.
Prolonged use of a painkiller for headaches can make them worse. Gastrointestinal disorders Frequency “Not known” (cannot be estimated from the available data): • Pancreatitis. Hepatobiliary disorders Frequency “Not known” (cannot be estimated from the available data): • Sphincter of Oddi dysfunction.
Paracetamol Very rare cases of serious skin reactions have been reported. Very rarely there have been reports of blood dyscrasias including thrombocytopaenia and agranulocytosis, but these were not necessarily causally related to paracetamol.
Hepatobiliary disorders Frequency “Not known” (cannot be estimated from the available data): • Hepatic dysfunction Metabolism and nutrition disorders Frequency “Not known” (cannot be estimated from the available data): • High anion gap metabolic acidosis.
4). Pyroglutamic acidosis may occur as a consequence of low glutathione levels in these patients. Drug dependence Repeated use of Paracetamol & Codeine Capsules can lead to drug dependence, even at therapeutic doses. 4). Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store.
Should be taken with caution by patients with impaired kidney or liver function. The hazards of overdose are greater in those with non-cirrhotic alcoholic liver disease. Do not take more medicine than the label tells you to. If you do not get better, talk to your doctor.
Do not give to children under 12 years. Contains paracetamol. Do not take anything else containing paracetamol while taking this medicine. Keep all medicines out of the reach of children.
The label will state:
Talk to a doctor at once if you take too much of this medicine, even if you feel well. 1 of the SPC • If you need to take this medicine continuously for more than 3 days you must speak to your doctor or pharmacist for advice • This medicine contains codeine which can cause addiction if you take it continuously for more than 3 days.
If you take this medicine for headaches for more than 3 days it can make them worse The leaflet (or combined label/leaflet) will state: Talk to a doctor at once if you take too much of this medicine even if you feel well. This is because too much paracetamol can cause delayed, serious liver damage.
(indications) • You should only take this product for a maximum of 3 days at a time. If you need to take it for longer than 3 days you should see your doctor or pharmacist for advice • This medicine contains codeine which can cause addiction if you take it continuously for more than 3 days.
1 of the SPC “Before you take this medicine” section • This medicine contains codeine which can cause addiction if you take it continuously for more than 3 days. This can give you withdrawal symptoms from the medicine when you stop taking it • If you take a painkiller for headaches for more than 3 days it can make them worse “How to take this medicine” section • Do not take for more than 3 days.
Hypersensitivity to any of the ingredients. Severe liver disease. 4). 6). In patients for whom it is known they are CYP2D6 ultra-rapid metabolisers. In patients with respiratory depression, chronic constipation or raised intracranial pressure.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Acetaminophen in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
Paracetamol & Codeine Capsules should be used for 3 days only to relieve symptoms. If no effective pain relief is achieved while taking the medicine, you should seek the advice of a healthcare professional. • This medicine contains codeine and can cause addiction if you take it continuously for more than 3 days.
When you stop taking it you may get withdrawal symptoms. You should talk to your doctor or pharmacist if you think you are suffering from withdrawal symptoms “Possible side effects” section Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible side effects not listed in this leaflet. uk/yellowcard, or search for MHRA Yellow Card in Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
” section If you take the medicine according to the instructions on the pack it is unlikely that you will become addicted to the medicine. However, if the following apply to you it is important that you talk to you doctor: • You need to take the medicine for longer periods of time • You need to take more than the recommended amount • When you stop taking the medicine you feel very unwell but you feel better if you start taking the medicine again Codeine Tolerance and opioid use disorder (abuse and dependence) Tolerance, physical and psychological dependence, and opioid use disorder (OUD) may develop upon repeated administration of opioids such as Paracetamol & Codeine Capsules.
Repeated use of Paracetamol & Codeine Capsules can lead to OUD. A higher dose and longer duration of opioid treatment can increase the risk of developing OUD. Abuse or intentional misuse of Paracetamol & Codeine Capsules may result in overdose and/or death.
g. major depression, anxiety and personality disorders). The patient should be made aware of the risks and signs of OUD as set out in the package leaflet. If these signs occur, patients should contact their physician. For patients who experience signs and symptoms of OUD, and/or exhibit drug seeking behaviours, review of concomitant opioids and psycho-active drugs (like benzodiazepines) and consultation with an addiction specialist may be required.
Sleep-related breathing disorders Opioids can cause sleep-related breathing disorders including central sleep apnoea (CSA) and sleep-related hypoxemia. Opioid use increases the risk of CSA in a dose- dependent fashion. In patients who present with CSA, consider decreasing the total opioid dosage.
Hyperalgesia As with other opioids, in case of insufficient pain control in response to an increased dose of codeine, the possibility of opioid-induced hyperalgesia should be considered. A dose reduction or treatment review may be indicated.
Hepatobiliary disorders Codeine may cause dysfunction and spasm of the sphincter of Oddi, thus increasing the risk of biliary tract symptoms and pancreatitis. Therefore, codeine/paracetamol has to be administered with caution in patients with pancreatitis and diseases of the biliary tract.
CYP2D6 metabolism Codeine is metabolised by the liver enzyme CYP2D6 into morphine, its active metabolite. If a patient has a deficiency or is completely lacking this enzyme an adequate analgesic effect will not be obtained. Estimates indicate that up to 7% […]